Skip to main content
. Author manuscript; available in PMC: 2021 Aug 20.
Published in final edited form as: Pain. 2021 Jun 1;162(6):1828–1839. doi: 10.1097/j.pain.0000000000002185

Table 2.

Patient surgical variables for the TAU and COLP groups.

Surgical variables TAU (n = 22) COLP (n = 19)

 No. of levels 3.1 ± 1.3 3.5 ± 1.4

 Duration of surgery (min) 161 ± 49 168 ± 53

 Blood loss during surgery (mL) 710 ± 632 622 ± 629

 Re-operation 4 (19%) 4 (21%)

 Spinal segments involved
  Cervical 5 (23%) 6 (32%)
  Thoracic 1 (5%) 1 (5%)
  Lumbar 17 (77%) 13 (68%)
  Sacral 1 (5%) 3 (16%)

 Surgical aspects involved
  Discectomy 3 (14%) 5 (26%)
  Laminectomy 20 (91%) 17 (90%)
  Fusion 21 (96%) 16 (84%)
  Other 2 (9%) 3 (16%)

 Indication(s) for surgery
  Spinal stenosis 19 (86%) 14 (74%)
  Spondylolisthesis 13 (59%) 10 (53%)
  Herniated disk 1 (5%) 2 (11%)
  Fracture 3 (14%) 1 (5%)
  Other 9 (41%) 9 (47%)

 Symptoms present at time of surgery
  Pain 21 (96%) 18 (95%)
  Weakness 3 (14%) 6 (32%)
  Numbness 3 (14%) 5 (26%)
  Other 3 (14%) 1 (5%)

Data are given in either mean ± SD or n(percent). Treatment groups were balanced across all surgical variables.

COLP, conditioned open-label placebo; TAU, treatment as usual.